Louise Rodino-Klapac - 17 Nov 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
President, R&D and Tech Ops
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac
Issuer symbol
SRPT
Transactions as of
17 Nov 2025
Net transactions value
-$84,400
Form type
4
Filing time
19 Nov 2025, 20:05:03 UTC
Previous filing
05 Sep 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rodino-Klapac Louise President, R&D and Tech Ops 215 FIRST STREET, SUITE 415, CAMBRIDGE /s/ Cristin Rothfuss, as Attorney-in-Fact for Louise Rodino-Klapac 19 Nov 2025 0001836218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $84,400 -4,582 -2% $18.42 224,030 17 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021.